Small bowel bacterial overgrowth and type 1 diabetes

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 6, 2009, Pages 419-423

  Ojetti, Veronica ^a   Pitocco, D ^a   Scarpellini, E ^a   Zaccardi, F ^a   Scaldaferri, F ^a   Gigante, G ^a   Gasbarrini, G ^a   Ghirlanda, G ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Diabetic autonomic neuropathy; Insulin requirement; Small bowel bacterial overgrowth; Type 1 diabetes

Indexed keywords

INSULIN; LACTULOSE;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BACTERIAL OVERGROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; GLYCEMIC CONTROL; HUMAN; HYDROGEN BREATH TEST; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PREVALENCE; SMALL BOWEL BACTERIAL OVERGROWTH;

ADULT; BACTERIA; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; MALE; MIDDLE AGED;

EID: 74949121505     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. HASLBECK M. Autonomic neuropathies in diabetes mellitus: diagnosis, therapy, risks. Z Gesamte Inn Med 1993; 48: 162-176.
2. VINIK AI, ERBAS T. Recognizing and treating diabetic autonomic neuropathy. Clev Clin J Med 2001; 68: 928-944.
3. FREEMAN R. The peripheral nervous system and diabetes. In: Joslin's Diabetes Mellitus. Weir G, Kahn R, King GL, Eds. Philadelphia, Lippincott, 2002.
4. AMERICAN DIABETES ASSOCIATION AND AMERICAN ACADEMY OF NEUROLOGY: Report and recommendations of the San Antonio Conference on diabetic neuropathy (Consensus Statement). Diabetes 1988; 37: 1000-1004.
5. PFEIFER MA WEINBERG CR, COOK DL, REENAN A, HALTER JB, ENSINCK JW, PORTE D Jr. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984; 7: 447-453.
6. EWING DJ. Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med 1978; 55: 321-327.
7. CLARKE BF, EWING DJ, CAMPBELL IW. Diabetic autonomic neuropathy. Diabetologia 1979; 17: 195-212.
8. LEVITT NS, STANSBERRY KB, WYNCHANK S, VINIK AI. The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care 1996; 19: 751-754.
9. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49: 95-108.
10. RATHMANN W, ZIEGLER D, JAHNKE M, HAASTERT B, GRIES FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 820-824.
11. MIETTINEN H, LEHTO S, SALOMAA V, MÄHÖNEN M, NIEMELÄ M, HAFFNER SM, PYÖRÄLÄ K, TUOMILEHTO J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998; 21: 69-75.
12. FAVA S, AZZOPARDI J, MUSCAT HA, FENNECH FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993; 16: 1615-1618.
13. KARAVANAKI-KARANASSIOU K. Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14: 1379-1386.
14. DI STEFANO M, CORAZZA GR. Treatment of small intestinal bacterial overgrowth and related symtoms by rifaximin. Chemotherapy 2005; 51(S1):103-109.
15. DONALD IP, KITCHINGHAM G, DONALD F, KUPFER RM. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc 1992; 40: 692-696.
16. PIMENTEL M, CHOW EJ, LIN HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-3506.
17. PIMENTEL M, CHOW EJ, LIN HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo controlled study. Am J Gastroenterol 2003; 98: 412-419.
18. CORAZZA GR, MENOZZI MG, STROCCHI A, RASCITI L, VAIRA D, LECCHINI R, AVANZINI P, CHEZZI C, GASBARRINI G. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990 98: 302-309.
19. RIORDAN SM, MCIVER CJ, WALKER BM, DUCOMBE VM, BOLIN TD, THOMAS MC. Bacteriological method for detecting small intestinal hypomotility. Am J Gastroenterol 1996; 91: 2399-2405.
20. SINGH VV, TOSKES PP. Small bowel bacterial overgrowth: Presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol 2004; 7: 19-28.
21. EWING DJ, CLARKE BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.
22. CAMILLERI M, MALAGELADA JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14: 420-427.
23. NUCERA G, GABRIELLI M, LUPASCU A, LAURITANO EC, SANTOLIQUIDO A, CREMONINI F, CAMMAROTA G, TONDI P, POLA P, GASBARRINI G, GASBARRINI A. Abnormal breath test sto lactose, fructose and sorbitol in Irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 1391-1395.
24. XU J, BJURSELL MK, HIMROD J, DENG S, CARMICHAEL LK, CHIANG HC, HOOPER LV GORDON JI. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299: 2074-2076.
25. RAYNER CK, SAMSOM M, JONES KL, HOROWITZ M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371-381.